ClinicalTrials.Veeva

Menu

Weight Loss and Appetite Reduction After Percutaneous Electrical Stimulation Dermatome T6

H

Hospital General Universitario Elche

Status and phase

Completed
Phase 3

Conditions

Weight Loss

Treatments

Procedure: PENS T6
Dietary Supplement: Normocaloric 2000 Kcal/day diet
Dietary Supplement: Hypocaloric 1200 Kcal/day diet
Procedure: TENS T11/T12

Study type

Interventional

Funder types

Other

Identifiers

NCT02810925
ClinGarci 16-2

Details and patient eligibility

About

The patients are randomized into 4 groups : Patients undergoing PENS of dermatome T6 in and a 1200 Kcal diet (Group 1), Patients undergoing PENS T6 and a 2000 Kcal/day, Patients undergoing transcutaneous electrical neurostimulation (TENS) of Dermatomes T11-T12 and following a 1200 Kcal diet and those patients following only a 1200 Kcal diet (Group 4). Weight loss, appetite and ghrelin levels at baseline and after treatment are investigated.

Full description

The patients were randomized into 4 groups using an Internet randomization module: Patients undergoing PENS of dermatome T6 in conjunction with the implementation of a 1200 Kcal diet (Group 1), Patients undergoing PENS T6 and following a normocaloric diet (2000 Kcal/day) (Group 2), Patients undergoing transcutaneous electrical neurostimulation (TENS) of dermatomes in right iliac fossa (Dermatomes T11-T12) and following a hypocaloric diet (1200 Kcal/day) (Group 3) and those patients following only a 1200 Kcal diet (Group 4).

Weight loss, appetite and ghrelin levels, at baseline and after treatment, are investigated.

Enrollment

200 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with obesity (BMI>30 Kg/m2) or overweight (BMI 25-30 Kg/m2)

Exclusion criteria

  • Untreated endocrine disease causing obesity
  • Serious psychiatric illness.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 4 patient groups, including a placebo group

PENS T6 and 1200 Kcal/day diet
Experimental group
Description:
Patients undergo 12 sessions of percutaneous electrical stimulation of dermatome T6 (PENS T6), weekly, during 12 weeks. During this period they follow a hypocaloric 1200 Kcal/day diet.
Treatment:
Dietary Supplement: Hypocaloric 1200 Kcal/day diet
Procedure: PENS T6
PENST6 + Normocaloric 2000 Kcal/day diet
Active Comparator group
Description:
Patients undergo 12 sessions of percutaneous electrical stimulation of dermatome T6 (PENS T6), weekly, during 12 weeks. During this period they follow a normocaloric 2000 Kcal/day diet.
Treatment:
Dietary Supplement: Normocaloric 2000 Kcal/day diet
Procedure: PENS T6
TENS T11/ T12 + 1200 Kcal/day diet
Placebo Comparator group
Description:
Patients undergo 12 sessions of transcutaneous electrical stimulation of dermatomes T11-T12 , weekly, during 12 weeks. During this period they follow a hypocaloric 1200 Kcal/day diet.
Treatment:
Dietary Supplement: Hypocaloric 1200 Kcal/day diet
Procedure: TENS T11/T12
1200 Kcal/day diet
Active Comparator group
Description:
Patients follow only a hypocaloric 1200 Kcal/day diet.
Treatment:
Dietary Supplement: Hypocaloric 1200 Kcal/day diet

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems